These results suggest that high expression of ZDHHC9 is associated with an immunosuppressive microenvironment and that ZDHHC9 can serve as an important marker for guiding the classification, diagnosis and prognosis of breast cancer, including TNBC, and developing specific targeted therapies. The gene discussed is ZDHHC9; the disease is breast carcinoma.